SLC39A1 adenovirus

The SLC39A1 gene, also known as ZIP1, belongs to the solute carrier family 39 (SLC39) family, a class of zinc transporters crucial for maintaining cellular zinc homeostasis. Zinc is an essential trace element involved in numerous biological processes, including enzyme catalysis, immune function, and gene regulation. SLC39A1 encodes a transmembrane protein that facilitates zinc entry into cells, particularly when extracellular zinc levels are low. Dysregulation of SLC39A1 has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and metabolic syndrome. Studies have shown that SLC39A1 expression is tissue-specific, with high levels observed in the prostate, brain, and intestine, suggesting a role in organ-specific zinc metabolism.

The SLC39A1 adenovirus is a recombinant viral vector designed to deliver the SLC39A1 gene to target cells for research or potential therapeutic applications. Adenoviral vectors are widely used in gene therapy due to their high transduction efficiency, broad tropism, and ability to infect both dividing and non-dividing cells. The SLC39A1 adenovirus enables researchers to overexpress the SLC39A1 gene in vitro or in vivo, enabling the study of zinc transport mechanisms, cellular responses to zinc deficiency or overload, and the gene''s role in disease progression. This tool is particularly valuable in cancer research, where altered zinc metabolism is frequently observed. For example, the SLC39A1 adenovirus can be used to study how zinc transport affects tumor growth, metastasis, or chemotherapy resistance.